BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7517747)

  • 1. CD23 antigen density is related to serum gamma globulin level, bone marrow reticulin pattern, and treatment in B chronic lymphocytic leukemia.
    Lavabre-Bertrand T; Exbrayat C; Bourquard P; Lavabre-Bertrand C; Fégueux N; Poncelet P; Rousset T; Taïb J; Emberger JM; Navarro M
    Leuk Lymphoma; 1994 Mar; 13(1-2):89-94. PubMed ID: 7517747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. When and how to treat elderly patients with chronic lymphocytic leukemia (C.L.L.)? The French Cooperative Group on C.L.L.
    Binet JL
    Hematol Oncol; 1993; 11 Suppl 1():38. PubMed ID: 8486339
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of residual disease in B-cell chronic lymphocytic leukemia patients in clinical and bone-marrow remission using CD5-CD19 markers and PCR study of gene rearrangements.
    Vuillier F; Claisse JF; Vandenvelde C; Travade P; Magnac C; Chevret S; Desablens B; Binet JL; Dighiero G
    Leuk Lymphoma; 1992 Jun; 7(3):195-204. PubMed ID: 1282428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular expression and serum circulating levels of CD23 in B-cell chronic lymphocytic leukemia. Implications for prognosis.
    Molica S; Levato D; Dell'Olio M; Matera R; Minervini M; Dattilo A; Carotenuto M; Musto P
    Haematologica; 1996; 81(5):428-33. PubMed ID: 8952156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative expression of CD23 and its ligand CD21 in chronic lymphocytic leukemia.
    Lopez-Matas M; Rodriguez-Justo M; Morilla R; Catovsky D; Matutes E
    Haematologica; 2000 Nov; 85(11):1140-5. PubMed ID: 11064465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of CD23 antigen expression in B-chronic lymphocytic leukaemia and its correlation with clinical parameters.
    Jurisic V; Colovic N; Kraguljac N; Atkinson HD; Colovic M
    Med Oncol; 2008; 25(3):315-22. PubMed ID: 18183502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic lymphocytic leukemia associated with bone marrow fibrosis: possible role of interleukin 1 alpha in the pathogenesis.
    Kimura A; Hyodo H; Nakata Y; Kuramoto A
    Am J Hematol; 1993 May; 43(1):47-50. PubMed ID: 8317461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble CD23 reliably reflects disease activity in B-cell chronic lymphocytic leukemia.
    Reinisch W; Willheim M; Hilgarth M; Gasché C; Mader R; Szepfalusi S; Steger G; Berger R; Lechner K; Boltz-Nitulescu G
    J Clin Oncol; 1994 Oct; 12(10):2146-52. PubMed ID: 7931486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment.
    Kusenda J; Babusíková O
    Neoplasma; 2004; 51(2):97-102. PubMed ID: 15190418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of fludarabine, cyclophosphamide/doxorubicin/prednisone, and cyclophosphamide/doxorubicin/vincristine/prednisone in advanced forms of chronic lymphocytic leukemia: preliminary results of a controlled clinical trial. The French Cooperative Group on Chronic Lymphocytic Leukemia.
    Semin Oncol; 1993 Oct; 20(5 Suppl 7):21-3. PubMed ID: 8235691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD23 and chronic lymphocytic leukemia.
    Sarfati M
    Blood Cells; 1993; 19(3):591-6; discussion 597-9. PubMed ID: 8018941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia.
    Rai KR; Peterson BL; Appelbaum FR; Kolitz J; Elias L; Shepherd L; Hines J; Threatte GA; Larson RA; Cheson BD; Schiffer CA
    N Engl J Med; 2000 Dec; 343(24):1750-7. PubMed ID: 11114313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of soluble CD23, but not soluble CD25, predict disease progression in early stage B-cell chronic lymphocytic leukemia.
    Knauf WU; Langenmayer I; Ehlers B; Mohr B; Adorf D; Nerl CH; Hallek M; Zwingers TH; Emmerich B; Thiel E
    Leuk Lymphoma; 1997 Nov; 27(5-6):523-32. PubMed ID: 9477135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PHAGOCYTOSIS AND EXPRESSION OF FCg-RECEPTORS AND CD180 ON MONOCYTES IN CHRONIC LYMPHOCYTIC LEUKEMIA.
    Tsertsvadze T; Mitskevich N; Bilanishvili A; Girdaladze D; Porakishvili N
    Georgian Med News; 2017 Sep; (270):88-93. PubMed ID: 28972490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating levels of soluble CD23 reflect clinical and biological features of leukemic B-cell chronic lymphoproliferative disorders.
    Vinante F; Vassanelli A; Zanotti R; Nadali G; Krampera M; Vincenzi C; Morosato L; Chilosi M; Pizzolo G
    Int J Clin Lab Res; 1995; 25(4):189-94. PubMed ID: 8788546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of severe refractory autoimmune hemolytic anemia in B-cell chronic lymphocytic leukemia with alemtuzumab (humanized CD52 monoclonal antibody).
    Karlsson C; Hansson L; Celsing F; Lundin J
    Leukemia; 2007 Mar; 21(3):511-4. PubMed ID: 17215854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High dose chlorambucil versus Binet's modified cyclophosphamide, doxorubicin, vincristine, and prednisone regimen in the treatment of patients with advanced B-cell chronic lymphocytic leukemia. Results of an international multicenter randomized trial. International Society for Chemo-Immunotherapy, Vienna.
    Jaksic B; Brugiatelli M; Krc I; Losonczi H; Holowiecki J; Planinc-Peraica A; Kusec R; Morabito F; Iacopino P; Lutz D
    Cancer; 1997 Jun; 79(11):2107-14. PubMed ID: 9179056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intense reversal of bone marrow angiogenesis after sequential fludarabine-induction and alemtuzumab-consolidation therapy in advanced chronic lymphocytic leukemia.
    Molica S; Montillo M; Ribatti D; Mirabelli R; Tedeschi A; Ricci F; Veronese S; Vacca A; Morra E
    Haematologica; 2007 Oct; 92(10):1367-74. PubMed ID: 17768114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of chemotherapy on bone marrow in patients with chronic lymphocytic leukaemia.
    Lemancewicz D; Dziecioł J; Kłoczko J; Piszcz J
    Folia Morphol (Warsz); 2004 Nov; 63(4):485-9. PubMed ID: 15712148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD8 expression on B cells in chronic lymphocytic leukemia: a case report and review of the literature.
    Islam A; Vladutiu AO; Donahue T; Akhter S; Sands AM; Ambrus JL
    Arch Pathol Lab Med; 2000 Sep; 124(9):1361-3. PubMed ID: 10975939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.